Neurology

Two promising biomarkers, the kappa free light chains (kFLC) index and central vein sign (CVS), have been incorporated into the revised 2024 McDonald criteria, offering improved diagnostic precision for multiple sclerosis (MS) and radiologically isolated syndrome (RIS).

EEG suppression after seizures may signal increased SUDEP risk in children with epilepsy, according to a new study evaluating clinical and electrophysiological indicators.

VMAT2 inhibitors may offer effective symptom relief for pediatric hyperkinetic movement disorders, according to a new retrospective study reviewing over a decade of clinical use.

Breast cancer survivors may face a lower risk of Alzheimer’s disease than their cancer-free peers, according to a large retrospective cohort study examining long-term cognitive outcomes following treatment.

An emerging treatment model for migraine integrates behavioral and pharmacologic approaches via telehealth, potentially improving access and outcomes for patients with this highly disabling neurological condition.

Depression and anxiety, not motor decline, are the strongest predictors of quality of life in patients with progressive supranuclear palsy (PSP), according to a new study that underscores the pressing need for comprehensive symptom management beyond traditional motor assessments.

Clinical evaluation of small fiber neuropathy (SFN) remains inconsistent across neurology subspecialties, with survey data revealing wide variation in diagnostic practices, even when faced with common patient scenarios.

In a breakthrough that could accelerate research into Sudden Unexpected Death in Epilepsy (SUDEP), researchers have demonstrated that a state-of-the-art AI model, GPT-4o, can accurately extract neural projections from scientific literature.